Early research (Phase 1)Study completedNCT00004178What this trial is testingGene Therapy in Treating Patients With CancerWho this might be right forCancer Roger Williams Medical Center
Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Not applicableStudy completedNCT01129167What this trial is testingFrequency of Methods of Local Invasion of Pancreatic AdenocarcinomaWho this might be right forPancreatic Cancer Columbia University 1,052
Post-approval studies (Phase 4)UnknownNCT00274885What this trial is testingRelationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal CancerWho this might be right forCancer GERCOR - Multidisciplinary Oncology Cooperative Group 58
Early research (Phase 1)Study completedNCT00006981What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced CancerWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Not applicableEnded earlyNCT00087191What this trial is testingEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerWho this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Study completedNCT00005648What this trial is testingGemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic CancerWho this might be right forPancreatic Neoplasms Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 688
Early research (Phase 1)Study completedNCT01131234What this trial is testingGamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+49 more National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Looking for participantsNCT04851119What this trial is testingTegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsWho this might be right forColorectal CarcinomaEndometrial CarcinomaMelanoma+19 more Children's Oncology Group 147
Early research (Phase 1)Study completedNCT01145456What this trial is testingGamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid TumorsWho this might be right forAdenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic Cancer+2 more National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05736731What this trial is testingEvaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultSolid TumorPancreatic Cancer+13 more A2 Biotherapeutics Inc. 160
Testing effectiveness (Phase 2)Study completedNCT00265876What this trial is testingAZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryWho this might be right forPancreatic Cancer NCIC Clinical Trials Group 34
Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT06907043What this trial is testingPARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.Who this might be right forAdvanced Solid Tumors Eikon Therapeutics 130
Very early researchEnded earlyNCT00867126What this trial is testingPioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With GemcitabineWho this might be right forPancreatic Cancer University of Texas Southwestern Medical Center 6
Early research (Phase 1)Study completedNCT00003427What this trial is testingOxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerWho this might be right forAnal CancerColorectal CancerEsophageal Cancer+7 more Memorial Sloan Kettering Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT00019786What this trial is testingIsolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver MetastasesWho this might be right forColorectal CancerIslet Cell TumorLiver Cancer+2 more National Institutes of Health Clinical Center (CC) 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT03073785What this trial is testingHypofractionated Stereotactic Body Radiation & Fluorouracil or Capecitabine for Locally Advanced Pancreatic CancerWho this might be right forPancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage I Pancreatic Cancer AJCC v6 and v7+7 more University of Nebraska 46
Very early researchStudy completedNCT00436410What this trial is testingTumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic CancerWho this might be right forAdrenocortical CarcinomaBreast CancerColorectal Cancer+7 more National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Study completedNCT00161213What this trial is testingGemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer University of Medicine and Dentistry of New Jersey 44